Department of Obstetrics and Gynaecology

Long-term effect of neoadjuvant denosumab treatment in high-risk early breast cancer (GeparX) (2025) Link T, Reinisch M, Just M, Untch M, Filmann N, Stötzer O, Denkert C, et al. Journal article Correction to: Gender-affirming hormonal therapy induces a gender-concordant fecal metagenome transition in transgender individuals (BMC Medicine, (2024), 22, 1, (346), 10.1186/s12916-024-03548-z) (2025) Liwinski T, Auer MK, Schröder J, Pieknik I, Casar C, Schwinge D, Henze L, et al. Journal article, Erratum Feasibility of virtual T2-weighted fat-saturated breast MRI images by convolutional neural networks (2025) Liebert A, Hadler D, Ehring C, Schreiter H, Brock L, Kapsner L, Eberle J, et al. Journal article Attitudes of female carriers of X-linked hypohidrotic ectodermal dysplasia towards prenatal treatment and their decisions during a pregnancy with a male fetus (2025) Schneider H, Schneider M, Lia M, Grange DK, Hadj-Rabia S, Clarke A, Fete M, et al. Journal article Effect of delayed isolation of peripheral blood mononuclear cells on cell viability and functionality (2025) Lehle S, Völkl S, Seitz K, Goossens C, Emons J, Rübner M, Uhrig S, et al. Journal article Lessons learned from a candidate gene study investigating aromatase inhibitor treatment outcome in breast cancer (2025) Hoppe R, Winter S, Lo WY, Michailidou K, Bolla MK, Keeman R, Wang Q, et al. Journal article A case of metachronous cervical and early-stage breast cancer (2025) Iason P, Emons J, Burghaus S, Paul G, Stübs F, Seibold A, Füller A, et al. Journal article Atezolizumab Monotherapy Window Preceding Combined Neoadjuvant Chemotherapy and Immune Therapy in Triple-Negative Breast Cancer-The neoMono Trial (2025) Kolberg HC, Schumacher J, Erber R, Braun M, Fasching P, Grischke EM, Schem C, et al. Journal article Study Protocol of SURVIVE HERoes (NCT06643585): Trastuzumab Deruxtecan for molecular relapse in HER2+/ Low early breast cancer with ctDNA positivity after primary therapy (2025) Pfister K, Friedl TW, Hartkopf A, Mergel F, Huesmann S, Mehmeti F, Schäffler H, et al. Journal article Adjuvant ribociclib plus nonsteroidal aromatase inhibitor therapy in patients with HR-positive/HER2-negative early breast cancer: 5-year follow-up of NATALEE efficacy outcomes and updated overall survival (2025) Crown J, Stroyakovskii D, Yardley DA, Huang CS, Fasching P, Bardia A, Chia S, et al. Journal article